IMMX
Immix Biopharma Inc

4,497
Mkt Cap
$482.42M
Volume
2.01M
52W High
$11.61
52W Low
$1.34
PE Ratio
-11.59
IMMX Fundamentals
Price
$9.11
Prev Close
$9.68
Open
$9.60
50D MA
$7.33
Beta
1.28
Avg. Volume
808,732.60
EPS (Annual)
-$0.7641
P/B
36.41
Rev/Employee
$0.00
$45.62
Loading...
Loading...
News
all
press releases
Immix Biopharma (NASDAQ:IMMX) Shares Down 8.9% - Should You Sell?
Immix Biopharma (NASDAQ:IMMX) Trading Down 8.9% - What's Next...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - What's Next?
Immix Biopharma (NASDAQ:IMMX) Trading Up 6.3% - Should You Buy...
MarketBeat·5d ago
News Placeholder
Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Drops By 13.4%
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·5d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Hits New 12-Month High - Here's Why
Immix Biopharma (NASDAQ:IMMX) Sets New 52-Week High - Should You Buy...
MarketBeat·6d ago
News Placeholder
Immix Biopharma (IMMX) to Release Earnings on Monday
Immix Biopharma (NASDAQ:IMMX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered Immix Biopharma from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·7d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Hits New 12-Month High - Should You Buy?
Immix Biopharma (NASDAQ:IMMX) Sets New 12-Month High - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Coverage Initiated by Analysts at Citizens Jmp
Citizens Jmp began coverage on shares of Immix Biopharma in a research report on Monday. They issued a "market outperform" rating and a $23.00 price target for the company...
MarketBeat·13d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Immix Biopharma from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·15d ago
News Placeholder
Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Rises By 31.9%
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling...
MarketBeat·1mo ago
<
1
2
...
>

Latest IMMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.